This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

Healthy Skeptic

By Kevin Roche

The Healthy Skeptic podcast provides general information about health care and the health system. It is produced by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached via email at khroche@healthy-skeptic.com

  1. 1.
    some coronavirus numbers05/09/2020
    4:57
  2. 2.
    coronavirus status05/05/2020
    6:33
  3. 3.
    Coronavirus basics05/05/2020
    4:57
  4. 4.
    coronavirus03/26/2020
    4:01
  5. 5.
    national health expenditures03/26/2020
    3:19
  6. 6.
    drug prices03/26/2020
    3:54
  7. 7.
    mental illness and Medicare spending03/26/2020
    3:37
  8. 8.
    more coronavirus talk03/22/2020
    4:55
  1. 9.
    financial incentives03/22/2020
    2:35
  2. 10.
    MedPac Part Tres03/22/2020
    3:16
  3. 11.
    medPac03/22/2020
    3:08
  4. 12.
    MedPAC report03/22/2020
    3:21
  5. 13.
    cost of drug development03/22/2020
    3:11
  6. 14.
    life-sustaining care03/22/2020
    3:09
  7. 15.
    virus common sense03/12/2020
    4:17
  8. 16.
    drug pricing03/12/2020
    3:42
  9. 17.
    national helath spending03/12/2020
    2:53
  10. 18.
    spending by condition03/12/2020
    4:29
  11. 19.
    drug company profitability03/06/2020
    3:12
  12. 20.
    helping doctors with medication adherence03/06/2020
    3:16
  13. 21.
    school choice03/06/2020
    3:40
  14. 22.
    bipartisan reform03/03/2020
    3:52
  15. 23.
    employer plan spending through 201803/03/2020
    4:31
  16. 24.
    physician management styles03/03/2020
    4:02
  17. 25.
    health economists change the health system03/03/2020
    4:00
  18. 26.
    dug company payments to doctors03/03/2020
    3:42
  19. 27.
    hospitals and charity care03/02/2020
    2:56
  20. 28.
    mobile portal for diabetes03/02/2020
    2:56
  21. 29.
    2019 drug trend report03/02/2020
    3:22
  22. 30.
    patient assessment of physicians03/02/2020
    3:15
  23. 31.
    physician practice acquistions03/02/2020
    3:57
  24. 32.
    specialty consultations03/02/2020
    3:38
  25. 33.
    high deductible plan enrollee utilization03/02/2020
    3:42
  26. 34.
    concentration in health spending02/28/2020
    4:43
  27. 35.
    digital health02/14/2020
    3:39
  28. 36.
    price variation02/14/2020
    4:09
  29. 37.
    reference based pricing for drugs02/12/2020
    3:25
  30. 38.
    medical homes02/12/2020
    3:21
  31. 39.
    ACO primary care02/12/2020
    2:39
  32. 40.
    who pays for and gets health services02/08/2020
    4:30
  33. 41.
    malpractice and quality02/08/2020
    2:50
  34. 42.
    benefit design and utilization02/04/2020
    4:12
  35. 43.
    detailing of physicians02/04/2020
    3:17
  36. 44.
    electronic transactions02/04/2020
    3:37
  37. 45.
    predicting hospitalizations01/30/2020
    3:06
  38. 46.
    physician selection of patients01/30/2020
    4:25
  39. 47.
    out of network billing01/30/2020
    3:56
  40. 48.
    beneficiary savings in MA01/30/2020
    3:23
  41. 49.
    cancer treatment in hospital outpatient depts01/26/2020
    3:10
  42. 50.
    car-t therapy costs01/26/2020
    3:31
  43. 51.
    ma hospital quality01/26/2020
    3:26
  44. 52.
    single payer costs01/26/2020
    3:37
  45. 53.
    decision aids01/26/2020
    2:49
  46. 54.
    venture capital activity in 201901/26/2020
    4:28
  47. 55.
    administrative expenses01/16/2020
    4:36
  48. 56.
    broad networks01/16/2020
    3:47
  49. 57.
    bundled payments01/16/2020
    2:51
  50. 58.
    clinical decision support01/13/2020
    3:08
  51. 59.
    superutilizer patient management01/13/2020
    4:01
  52. 60.
    private and public payer hospital rates01/08/2020
    3:56
  53. 61.
    medicare spending trends01/08/2020
    3:34
  54. 62.
    peer influence on product diffusion01/08/2020
    3:43
  55. 63.
    hospital consolidation and quality01/05/2020
    2:44
  56. 64.
    minnesota health care spending01/05/2020
    4:43
  57. 65.
    looking forward to 202012/31/2019
    4:17
  58. 66.
    the decade in health care12/31/2019
    3:38
  59. 67.
    high cost patients12/23/2019
    3:56
  60. 68.
    statistics in oncology trials12/23/2019
    4:16
  61. 69.
    high cost hospitals12/19/2019
    4:17
  62. 70.
    housing vouchers12/19/2019
    3:37
  63. 71.
    ma chart reviews12/17/2019
    3:46
  64. 72.
    advance planning12/17/2019
    3:06
  65. 73.
    medicare advantage plan switching12/13/2019
    3:16
  66. 74.
    deloitte consumer survey12/13/2019
    3:46
  67. 75.
    high deductible plans and diabetes12/11/2019
    3:31
  68. 76.
    specialist payments12/10/2019
    3:13
  69. 77.
    national health spending12/10/2019
    4:50
  70. 78.
    medical cost trend12/06/2019
    3:19
  71. 79.
    rural access to specialists12/05/2019
    3:57
  72. 80.
    ma spillovers12/05/2019
    3:03
  73. 81.
    patient reported information12/03/2019
    3:16
  74. 82.
    life expectancy12/02/2019
    3:38
  75. 83.
    ideology in research12/02/2019
    4:50
  76. 84.
    price transparency rules11/26/2019
    3:38
  77. 85.
    retail drug prices11/26/2019
    4:15
  78. 86.
    medical device purchasing11/20/2019
    3:52
  79. 87.
    medicare annual wellness visits11/20/2019
    3:42
  80. 88.
    quality programs11/18/2019
    3:48
  81. 89.
    end of life care11/18/2019
    3:53
  82. 90.
    HAC reductions11/14/2019
    4:24
  83. 91.
    OECD report11/14/2019
    3:15
  84. 92.
    readmission reduction program11/12/2019
    3:48
  85. 93.
    payment method for specialists11/12/2019
    2:49
  86. 94.
    provider consolidation and Medicare11/12/2019
    3:41
  87. 95.
    effects of cost-sharing11/08/2019
    4:30
  88. 96.
    340B program profits11/07/2019
    2:59
  89. 97.
    aco savings11/07/2019
    3:08
  90. 98.
    provider consolidation11/05/2019
    4:25
  91. 99.
    mercer on benefits11/01/2019
    3:21
  92. 100.
    functional medicine11/01/2019
    2:46
  93. 101.
    clinician burnout10/30/2019
    2:53
  94. 102.
    massachusetts cost control10/30/2019
    4:28
  95. 103.
    persistent high-spenders10/29/2019
    3:33
  96. 104.
    specialists in ACOs10/29/2019
    3:22
  97. 105.
    national health spending10/24/2019
    3:52
  98. 106.
    pbms and Part D10/23/2019
    3:27
  99. 107.
    regulatory burdens10/22/2019
    3:06
  100. 108.
    fraud and abuse rule changes10/21/2019
    3:17
  101. 109.
    cardiac testing10/21/2019
    4:05
  102. 110.
    MA plans and home health quality10/17/2019
    3:52
  103. 111.
    price transparency10/16/2019
    3:02
  104. 112.
    comprehensive care management10/15/2019
    3:08
  105. 113.
    waste in US health spending10/14/2019
    4:47
  106. 114.
    GAO audit of CMS quality measures10/14/2019
    3:13
  107. 115.
    accuracy of records of physician activities10/14/2019
    3:34
  108. 116.
    aco performance10/14/2019
    3:21
  109. 117.
    nurse prescribing10/14/2019
    3:27
  110. 118.
    ma plans and competition10/07/2019
    4:14
  111. 119.
    payment levels and access10/07/2019
    3:42
  112. 120.
    patient experience measures10/03/2019
    3:51
  113. 121.
    employer health plans10/03/2019
    4:51
  114. 122.
    end of life care10/03/2019
    3:20
  115. 123.
    diseases in different countries09/30/2019
    3:15
  116. 124.
    administrative costs09/30/2019
    3:51
  117. 125.
    hospital concentration09/30/2019
    4:03
  118. 126.
    medicaid drug spending09/30/2019
    3:39
  119. 127.
    hospital coding09/24/2019
    3:59
  120. 128.
    physician practice patterns09/24/2019
    5:00
  121. 129.
    hospital administered drugs09/24/2019
    3:07
  122. 130.
    physician drug rep interactions09/19/2019
    4:02
  123. 131.
    ma plan admin costs09/19/2019
    3:43
  124. 132.
    hospital star ratings09/19/2019
    3:18
  125. 133.
    ma spillovers09/19/2019
    3:10
  126. 134.
    mobile health09/19/2019
    3:20
  127. 135.
    price transparency09/19/2019
    3:30
  128. 136.
    diffusion of medical knowledge09/11/2019
    3:38
  129. 137.
    skilled nursing facility star ratings and outcomes09/10/2019
    3:17
  130. 138.
    Medicare and private health plan use of post-acute care09/09/2019
    4:09
  131. 139.
    one hospital system's abuse of market power09/06/2019
    2:34
  132. 140.
    value based purchasing09/06/2019
    3:27
  133. 141.
    practice size and outcomes09/05/2019
    4:02
  134. 142.
    risk adjusting hospital payments09/05/2019
    4:05
  135. 143.
    RVU committees09/03/2019
    4:00
  136. 144.
    drug pricing09/03/2019
    2:55
  137. 145.
    association of education and cause of death09/03/2019
    3:50
  138. 146.
    medical homes and chronic disease patients08/28/2019
    2:58
  139. 147.
    unintended HRRP consequences08/27/2019
    3:37
  140. 148.
    relative risk of Medicare beneficiaries08/27/2019
    4:16
  141. 149.
    health spending and social spending08/23/2019
    5:00
  142. 150.
    physicians and risk assessment08/23/2019
    4:27
  143. 151.
    employee health costs08/21/2019
    4:14
  144. 152.
    large employer health care trends08/20/2019
    4:38
  145. 153.
    hospital quality rating systems08/19/2019
    3:57
  146. 154.
    defective psychology research08/16/2019
    2:39
  147. 155.
    commercial hospital price trends08/15/2019
    3:46
  148. 156.
    research designs08/14/2019
    3:20
  149. 157.
    drug cost-sharing assistance programs08/14/2019
    4:12
  150. 158.
    rural ACOs08/13/2019
    4:00
  151. 159.
    health insurer profits08/09/2019
    5:48
  152. 160.
    defective health research08/08/2019
    4:14
  153. 161.
    malpractice liability08/07/2019
    3:21
  154. 162.
    self-funded plans08/06/2019
    3:47
  155. 163.
    medicaid managed care08/05/2019
    3:50
  156. 164.
    monopsony power in health care08/01/2019
    5:00
  157. 165.
    primary care spending08/01/2019
    3:41
  158. 166.
    milliman 2019 medical cost index08/01/2019
    5:00
  159. 167.
    generic drug prices08/01/2019
    3:56
  160. 168.
    dementia cost to Medicare08/01/2019
    3:51
  161. 169.
    employer health insurance07/25/2019
    3:40
  162. 170.
    [persistently high cost patients07/24/2019
    4:40
  163. 171.
    Alternative quality contract results in Massachusetts07/23/2019
    3:40
  164. 172.
    age and health spending07/22/2019
    4:10
  165. 173.
    use of biosimilars07/21/2019
    2:47
  166. 174.
    reference pricing07/21/2019
    4:19
  167. 175.
    capitated physician reimbursement07/21/2019
    3:26
  168. 176.
    sources of malpractice claims07/21/2019
    3:09
  169. 177.
    readmission penalties related to surgeries07/21/2019
    3:53
  170. 178.
    physician recruiting incentives07/19/2019
    3:53
  171. 179.
    using private plans for public health benefits07/19/2019
    4:43
  172. 180.
    physicians set the RVUs07/19/2019
    4:28
  173. 181.
    physicians as patients07/09/2019
    4:59
  174. 182.
    ehrs and doctor burnout07/09/2019
    3:27
  175. 183.
    value from more medical spending?07/09/2019
    4:22
  176. 184.
    internet ratings and physician choice07/02/2019
    4:21
  177. 185.
    hospital pricing to commercial health plans07/01/2019
    4:25
  178. 186.
    cancer drug pipeline`07/01/2019
    3:16
  179. 187.
    computer programs and health decision-making06/27/2019
    4:46
  180. 188.
    ACOs and Medicare Savings06/26/2019
    4:30
  181. 189.
    nursing home quality ratings06/26/2019
    4:16
  182. 190.
    2020 medical cost trend06/24/2019
    3:58
  183. 191.
    employer-sponsored health care06/21/2019
    3:52
  184. 192.
    network performance06/20/2019
    3:50
  185. 193.
    use of adjunct providers06/20/2019
    4:23
  186. 194.
    use of nurse practitioners and physician assistants to care for complex patients06/19/2019
    4:31
  187. 195.
    more on survey methodology06/18/2019
    3:43
  188. 196.
    high cost claims06/18/2019
    5:00
  189. 197.
    survey methodology issues06/17/2019
    4:59
  190. 198.
    antioxidants, a cautionary tale06/17/2019
    4:35
  191. 199.
    interventions for high cost patients06/17/2019
    3:07
  192. 200.
    drug company payments to prescribers06/17/2019
    4:38

Listen to Healthy Skeptic now.

Listen to Healthy Skeptic in full in the Spotify app